724 related articles for article (PubMed ID: 30635637)
1. Tau PET imaging in neurodegenerative tauopathies-still a challenge.
Leuzy A; Chiotis K; Lemoine L; Gillberg PG; Almkvist O; Rodriguez-Vieitez E; Nordberg A
Mol Psychiatry; 2019 Aug; 24(8):1112-1134. PubMed ID: 30635637
[TBL] [Abstract][Full Text] [Related]
2. Overview of tau PET molecular imaging.
Cassinelli Petersen G; Roytman M; Chiang GC; Li Y; Gordon ML; Franceschi AM
Curr Opin Neurol; 2022 Apr; 35(2):230-239. PubMed ID: 35191407
[TBL] [Abstract][Full Text] [Related]
3. Symptomatology in 4-repeat tauopathies is associated with data-driven topology of [
Schönecker S; Palleis C; Franzmeier N; Katzdobler S; Ferschmann C; Schuster S; Finze A; Scheifele M; Prix C; Fietzek U; Weidinger E; Nübling G; Vöglein J; Patt M; Barthel H; Sabri O; Danek A; Höglinger GU; Brendel M; Levin J;
Neuroimage Clin; 2023; 38():103402. PubMed ID: 37087820
[TBL] [Abstract][Full Text] [Related]
4. In vitro evaluation of [
Varlow C; Mathis CA; Vasdev N
Nucl Med Biol; 2024; 130-131():108891. PubMed ID: 38458074
[TBL] [Abstract][Full Text] [Related]
5. Discovery and preclinical characterization of [
Kroth H; Oden F; Molette J; Schieferstein H; Capotosti F; Mueller A; Berndt M; Schmitt-Willich H; Darmency V; Gabellieri E; Boudou C; Juergens T; Varisco Y; Vokali E; Hickman DT; Tamagnan G; Pfeifer A; Dinkelborg L; Muhs A; Stephens A
Eur J Nucl Med Mol Imaging; 2019 Sep; 46(10):2178-2189. PubMed ID: 31264169
[TBL] [Abstract][Full Text] [Related]
6. Ligand-based design of [
Lindberg A; Murrell E; Tong J; Mason NS; Sohn D; Sandell J; Ström P; Stehouwer JS; Lopresti BJ; Viklund J; Svensson S; Mathis CA; Vasdev N
Nat Commun; 2024 Jun; 15(1):5109. PubMed ID: 38877019
[TBL] [Abstract][Full Text] [Related]
7. Validating novel tau positron emission tomography tracer [F-18]-AV-1451 (T807) on postmortem brain tissue.
Marquié M; Normandin MD; Vanderburg CR; Costantino IM; Bien EA; Rycyna LG; Klunk WE; Mathis CA; Ikonomovic MD; Debnath ML; Vasdev N; Dickerson BC; Gomperts SN; Growdon JH; Johnson KA; Frosch MP; Hyman BT; Gómez-Isla T
Ann Neurol; 2015 Nov; 78(5):787-800. PubMed ID: 26344059
[TBL] [Abstract][Full Text] [Related]
8. Pathological correlations of [F-18]-AV-1451 imaging in non-alzheimer tauopathies.
Marquié M; Normandin MD; Meltzer AC; Siao Tick Chong M; Andrea NV; Antón-Fernández A; Klunk WE; Mathis CA; Ikonomovic MD; Debnath M; Bien EA; Vanderburg CR; Costantino I; Makaretz S; DeVos SL; Oakley DH; Gomperts SN; Growdon JH; Domoto-Reilly K; Lucente D; Dickerson BC; Frosch MP; Hyman BT; Johnson KA; Gómez-Isla T
Ann Neurol; 2017 Jan; 81(1):117-128. PubMed ID: 27997036
[TBL] [Abstract][Full Text] [Related]
9.
Graham TJA; Lindberg A; Tong J; Stehouwer JS; Vasdev N; Mach RH; Mathis CA
J Med Chem; 2023 Aug; 66(15):10628-10638. PubMed ID: 37487189
[TBL] [Abstract][Full Text] [Related]
10. Improved Tau PET SUVR Quantification in 4-Repeat Tau Phenotypes with [
Bischof GN; Brendel M; Barthel H; Theis H; Barbe M; Bartenstein P; Claasen J; Danek A; Höglinger G; Levin J; Marek K; Neumaier B; Palleis C; Patt M; Rullmann M; Saur D; Schroeter ML; Seibyl J; Song M; Stephens A; Sabri O; Drzezga A; van Eimeren T;
J Nucl Med; 2024 Jun; 65(6):952-955. PubMed ID: 38575191
[TBL] [Abstract][Full Text] [Related]
11. Head-to-head comparison of [
Aguero C; Dhaynaut M; Amaral AC; Moon SH; Neelamegam R; Scapellato M; Carazo-Casas C; Kumar S; El Fakhri G; Johnson K; Frosch MP; Normandin MD; Gómez-Isla T
Acta Neuropathol; 2024 Jan; 147(1):25. PubMed ID: 38280071
[TBL] [Abstract][Full Text] [Related]
12. Preclinical Characterization of the Tau PET Tracer [
Harada R; Lerdsirisuk P; Shimizu Y; Yokoyama Y; Du Y; Kudo K; Ezura M; Ishikawa Y; Iwata R; Shidahara M; Ishiki A; Kikuchi A; Hatano Y; Ishihara T; Onodera O; Iwasaki Y; Yoshida M; Taki Y; Arai H; Kudo Y; Yanai K; Furumoto S; Okamura N
J Nucl Med; 2023 Sep; 64(9):1495-1501. PubMed ID: 37321821
[TBL] [Abstract][Full Text] [Related]
13. Clinical development of passive tau-based immunotherapeutics for treating primary and secondary tauopathies.
Panza F; Dibello V; Sardone R; Castellana F; Zupo R; Lampignano L; Bortone I; Stallone R; Cirillo N; Damiani C; Altamura M; Bellomo A; Daniele A; Solfrizzi V; Lozupone M
Expert Opin Investig Drugs; 2023; 32(7):625-634. PubMed ID: 37405389
[TBL] [Abstract][Full Text] [Related]
14. Tau accumulation is associated with dopamine deficiency in vivo in four-repeat tauopathies.
Ferschmann C; Messerschmidt K; Gnörich J; Barthel H; Marek K; Palleis C; Katzdobler S; Stockbauer A; Fietzek U; Finze A; Biechele G; Rumpf JJ; Saur D; Schroeter ML; Rullmann M; Beyer L; Eckenweber F; Wall S; Schildan A; Patt M; Stephens A; Classen J; Bartenstein P; Seibyl J; Franzmeier N; Levin J; Höglinger GU; Sabri O; Brendel M; Scheifele M;
Eur J Nucl Med Mol Imaging; 2024 Jun; 51(7):1909-1922. PubMed ID: 38366196
[TBL] [Abstract][Full Text] [Related]
15. Additive value of [
Katzdobler S; Nitschmann A; Barthel H; Bischof G; Beyer L; Marek K; Song M; Wagemann O; Palleis C; Weidinger E; Nack A; Fietzek U; Kurz C; Häckert J; Stapf T; Ferschmann C; Scheifele M; Eckenweber F; Biechele G; Franzmeier N; Dewenter A; Schönecker S; Saur D; Schroeter ML; Rumpf JJ; Rullmann M; Schildan A; Patt M; Stephens AW; van Eimeren T; Neumaier B; Drzezga A; Danek A; Classen J; Bürger K; Janowitz D; Rauchmann BS; Stöcklein S; Perneczky R; Schöberl F; Zwergal A; Höglinger GU; Bartenstein P; Villemagne V; Seibyl J; Sabri O; Levin J; Brendel M;
Eur J Nucl Med Mol Imaging; 2023 Jan; 50(2):423-434. PubMed ID: 36102964
[TBL] [Abstract][Full Text] [Related]
16. Imaging tau pathology in Parkinsonisms.
Coakeley S; Strafella AP
NPJ Parkinsons Dis; 2017; 3():22. PubMed ID: 28685158
[TBL] [Abstract][Full Text] [Related]
17. High affinity radiopharmaceuticals based upon lansoprazole for PET imaging of aggregated tau in Alzheimer's disease and progressive supranuclear palsy: synthesis, preclinical evaluation, and lead selection.
Fawaz MV; Brooks AF; Rodnick ME; Carpenter GM; Shao X; Desmond TJ; Sherman P; Quesada CA; Hockley BG; Kilbourn MR; Albin RL; Frey KA; Scott PJ
ACS Chem Neurosci; 2014 Aug; 5(8):718-30. PubMed ID: 24896980
[TBL] [Abstract][Full Text] [Related]
18. Increased Cerebral Level of P2X7R in a Tauopathy Mouse Model by PET Using [
Kong Y; Cao L; Wang J; Zhuang J; Liu Y; Bi L; Qiu Y; Hou Y; Huang Q; Xie F; Yang Y; Shi K; Rominger A; Guan Y; Jin H; Ni R
ACS Chem Neurosci; 2024 Jun; 15(11):2112-2120. PubMed ID: 38776461
[TBL] [Abstract][Full Text] [Related]
19. Longitudinal Synaptic Loss in Primary Tauopathies: An In Vivo [
Holland N; Jones PS; Savulich G; Naessens M; Malpetti M; Whiteside DJ; Street D; Swann P; Hong YT; Fryer TD; Rittman T; Mulroy E; Aigbirhio FI; Bhatia KP; O'Brien JT; Rowe JB
Mov Disord; 2023 Jul; 38(7):1316-1326. PubMed ID: 37171832
[TBL] [Abstract][Full Text] [Related]
20. Cryo-EM Structures of Chronic Traumatic Encephalopathy Tau Filaments with PET Ligand Flortaucipir.
Shi Y; Ghetti B; Goedert M; Scheres SHW
J Mol Biol; 2023 Jun; 435(11):168025. PubMed ID: 37330290
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
